Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2025 | Challenges in implementing multi-omics predictive models for melanoma

Ines Pires da Silva, MD, PhD, Melanoma Institute Australia, Sydney, Australia, comments on how clinicians can utilize multi-omics predictive models in melanoma, expressing satisfaction with its progress, but notes that it will not be utilized as the final model without further refinement through a trial to ensure its robustness and improvement. Dr Pires da Silva highlights the need to optimize and simplify the model to make it more accessible and affordable for global use, while maintaining its effectiveness. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

So I’m going to probably divide this question into two parts okay so first are we happy with this model alone and my answer is I’m quite happy at this point but I would not utilize this as the final model okay I just want to highlight that so our goal is to implement this in a trial first that will make sure that first we have everything in place second that we make sure that we can improve probably this model and make it more robust okay once we have that finalized a second question which is your main question how can we utilize it around the world for example right so if it’s too complicated a model it might not be the best solution so what we want to do is to optimize but in a simplified way so we can utilize a very important model like a robust model but not as expensive so that’s the goal but we are still working on that

This transcript is AI-generated...

So I’m going to probably divide this question into two parts okay so first are we happy with this model alone and my answer is I’m quite happy at this point but I would not utilize this as the final model okay I just want to highlight that so our goal is to implement this in a trial first that will make sure that first we have everything in place second that we make sure that we can improve probably this model and make it more robust okay once we have that finalized a second question which is your main question how can we utilize it around the world for example right so if it’s too complicated a model it might not be the best solution so what we want to do is to optimize but in a simplified way so we can utilize a very important model like a robust model but not as expensive so that’s the goal but we are still working on that

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...